Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fischer

Showing results (1321-1330 of 1,361) with videos related to

Pageof 137
Sort By:
The New England Journal of Medicine|June 2, 2021
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial CarcinomaDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Future Oncology (London, England)|March 15, 2023
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summaryDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Advances in Wound Care|September 21, 2021
Inhibiting Fibroblast Mechanotransduction Modulates Severity of Idiopathic Pulmonary FibrosisArtem A Trotsyuk, Kellen Chen, Sun Hyung, et al.
Science Advances|February 6, 2021
Targeting oncoproteins with a positive selection assay for protein degradersVidyasagar Koduri, Leslie Duplaquet, Benjamin L Lampson, et al.
Nature Communications|July 27, 2021
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'David S Fischer, Meshal Ansari, Karolin I Wagner, et al.
The Journal of Physical Chemistry. B|June 4, 2014
All-atom empirical potential for molecular modeling and dynamics studies of proteinsA D MacKerell, D Bashford, M Bellott, et al.
Annals of Neurology|February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupJ H Simon, L D Jacobs, M Campion, et al.
Molecular Cell|August 22, 2025
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradationMikołaj Słabicki, Jiho Park, Radosław P Nowak, et al.
Mycoses|November 28, 2025
Management of Invasive Pulmonary Aspergillosis in Intensive Care Units: Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS)F Lamoth, W C Albrich, S Ragozzino, et al.
Nature|March 16, 2023
MEN1 mutations mediate clinical resistance to menin inhibitionFlorian Perner, Eytan M Stein, Daniela V Wenge, et al.
Pageof 137

Showing results (1321-1330 of 1,361) with videos related to

Sort By:
Pageof 137
The New England Journal of Medicine|June 2, 2021
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial CarcinomaDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Future Oncology (London, England)|March 15, 2023
Treatment of muscle-invasive urothelial cancer with nivolumab (CheckMate 274 study): a plain language summaryDean F Bajorin, J Alfred Witjes, Jürgen E Gschwend, et al.
Advances in Wound Care|September 21, 2021
Inhibiting Fibroblast Mechanotransduction Modulates Severity of Idiopathic Pulmonary FibrosisArtem A Trotsyuk, Kellen Chen, Sun Hyung, et al.
Science Advances|February 6, 2021
Targeting oncoproteins with a positive selection assay for protein degradersVidyasagar Koduri, Leslie Duplaquet, Benjamin L Lampson, et al.
Nature Communications|July 27, 2021
Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through 'reverse phenotyping'David S Fischer, Meshal Ansari, Karolin I Wagner, et al.
The Journal of Physical Chemistry. B|June 4, 2014
All-atom empirical potential for molecular modeling and dynamics studies of proteinsA D MacKerell, D Bashford, M Bellott, et al.
Annals of Neurology|February 5, 1998
Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research GroupJ H Simon, L D Jacobs, M Campion, et al.
Molecular Cell|August 22, 2025
Expanding the druggable zinc-finger proteome defines properties of drug-induced degradationMikołaj Słabicki, Jiho Park, Radosław P Nowak, et al.
Mycoses|November 28, 2025
Management of Invasive Pulmonary Aspergillosis in Intensive Care Units: Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS)F Lamoth, W C Albrich, S Ragozzino, et al.
Nature|March 16, 2023
MEN1 mutations mediate clinical resistance to menin inhibitionFlorian Perner, Eytan M Stein, Daniela V Wenge, et al.
Pageof 137